You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 February 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Friday that the US Food and Drug Administration (FDA) has accepted its New Drug Application for investigational oral giredestr...
20 February 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Friday that that the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax) in combination with biopharmace...
20 February 2026 - Phase 3 clinical stage pharmaceutical company Moleculin Biotech Inc (Nasdaq:MBRX) announced on Thursday that it has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain outstan...
20 February 2026 - Eupraxia Pharmaceuticals Inc (NASDAQ:EPRX) (TSX:EPRX), a Canada-based clinical-stage biotechnology company, announced on Thursday the pricing of its USD55m public offering of common shares and pre-funded warrants.The 6,428,574 comm...
20 February 2026 - Reacta Healthcare Ltd, a UK-based developer of food allergy diagnostic products, announced on Thursday the appointment of Richard Nagle as chair of its board of directors.Nagle has more than 30 years of experience in the pharmaceut...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe